Results 201 to 210 of about 49,840 (301)
Abstract Although poly(adenosine diphosphate‐ribose) polymerase inhibitors (PARPis) and bevacizumab were approved as first‐line maintenance for advanced ovarian cancer (OC), evidence comparing this combination with PARPi monotherapy, especially in BRCA‐mutated/homologous recombination‐deficient (HRD) patients, is lacking.
Lingying Wu +56 more
wiley +1 more source
On the evolution of the distribution of entrapped air at the tool/first ply interf‘ace during lay-up and debulk [PDF]
L. D. Bloom +3 more
openalex +1 more source
Primary Tracheobronchial Low-Grade Mucoepidermoid Carcinoma: A Report of a Rare Case. [PDF]
Sahu G, Barve A, Sharma H, Potdar P.
europepmc +1 more source
Combined Treatment of Disfiguring Facial Angiofibromas in Tuberous Sclerosis Complex With Surgical Debulking and Topical Sirolimus [PDF]
Jessica L. Patterson +4 more
openalex +1 more source
Mechanical Debridement of Methicillin-Sensitive Staphylococcus aureus Endocarditis: A Novel Approach Using Percutaneous Aspiration. [PDF]
Khakwani M +6 more
europepmc +1 more source
Stable expansion of high-grade serous ovarian cancer organoids requires a low-Wnt environment
Berger, H. +13 more
core +1 more source
Development of a Prognostic Nomogram in Epithelial Ovarian Cancer Based on KELIM: A Retrospective Study at TuDu Hospital, Vietnam. [PDF]
Pham HT, Vo TM, Phan LNN, Nguyen HT.
europepmc +1 more source

